Skip to main content

Table 3 Susceptibility of pathogens in period 1 and period 2

From: Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany

Antibiotic agent Period 1 (01/2012–12/2014) Period 2 (01/2015–04/2018) p value
Susceptible Resistant Susceptible Resistant
Overall n % n % n % n %
Ampicillin 31 34.4 59 65.6 33 32.4 69 67.6 0.76
Ceftriaxone 32 34.0 62 66.0 26 26.0 74 74.0 0.22
Ciprofloxacin 33 62.3 20 37.7 48 68.6 22 31.4 0.47
Meropenem 56 65.1 30 34.9 62 80.5 15 19.5 0.03
Ascites
Ampicillin 15 41.7 21 58.3 14 29.8 33 70.2 0.26
Ceftriaxone 13 36.1 23 63.9 8 18.2 36 81.8 0.07
Ciprofloxacin 13 68.4 6 31.6 23 63.9 13 36.1 0.74
Meropenem 23 67.6 11 32.4 31 77.5 9 22.5 0.34
Blood
Ampicillin 9 27.3 24 72.7 5 22.7 17 77.3 0.71
Ceftriaxone 10 27.8 26 72.2 6 27.2 16 72.7 0.97
Ciprofloxacin 11 61.1 7 38.9 10 58.8 7 41.2 0.89
Meropenem 19 57.6 14 42.4 15 75.0 5 25.0 0.20
Urine
Ampicillin 7 33.3 14 66.7 14 42.4 19 57.6 0.50
Ceftriaxone 9 40.9 13 59.1 12 35.3 22 64.7 0.67
Ciprofloxacin 9 56.3 7 43.8 15 88.2 2 11.8 0.06
Meropenem 14 73.7 5 26.3 16 94.1 1 5.9 0.18
  1. N: number of susceptible or resistant results